NIAID Now

Filter NIAID Now Blog by year:
2025 | 2024 | 2023

4 Results

Vaccine Protective Against H5N1 Influenza from Cattle

Experimental H5N1 vaccine fully protective in mice against virus circulating in U.S. cattle.

NIAID Study Describes Successful Treatment Regimen for Person with Multidrug-Resistant HIV

A NIAID study describes the successful treatment of a person with multidrug-resistant (MDR) HIV with a regimen including the monoclonal antibody UB-421 (semzuvolemab) and lenacapavir-based ART.

Subclinical Disease in Monkeys Exposed to H5N1 by Mouth and Stomach

Drinking raw milk contaminated with H5N1 virus can cause infection but may be less severe. Regardless, exposure by raw milk should be avoided.

Measuring Innovation: Laboratory Infrastructure to Deliver Essential HIV Clinical Trial Results

HIV clinical trials network laboratory functions will continue to evolve to align with scientific priorities and research approaches.

Contact

Contact the NIAID Media Team.
301-402-1663

niaidnews@niaid.nih.gov